These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 15518757)
21. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors? Nashan B Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616 [TBL] [Abstract][Full Text] [Related]
22. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy. El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298 [TBL] [Abstract][Full Text] [Related]
23. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients. Chang HR; Lin CC; Lian JD Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339 [TBL] [Abstract][Full Text] [Related]
24. Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy. Ji SM; Li LS; Sha GZ; Chen JS; Liu ZH Transplant Proc; 2007 Jun; 39(5):1402-5. PubMed ID: 17580148 [TBL] [Abstract][Full Text] [Related]
25. Steroid-free immunosuppression in kidney transplant recipients and prograf monotherapy: an interim analysis of a prospective multicenter trial. Bäckman L; Aselius H; Lindberger K; Svensson L; Strömbom U; Olausson E; Hadimeri H; Deurell SI; Norrby J; Gäbel M; Ebermark A; Olausson M Transplant Proc; 2006 Oct; 38(8):2654-6. PubMed ID: 17098029 [TBL] [Abstract][Full Text] [Related]
26. Switching immunosuppression from cyclosporine to tacrolimus improves long-term kidney function: a 6-year study. Hohage H; Welling U; Zeh M; Gerhardt U; Suwelack B Transplant Proc; 2005 May; 37(4):1898-9. PubMed ID: 15919497 [TBL] [Abstract][Full Text] [Related]
27. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259 [TBL] [Abstract][Full Text] [Related]
28. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction]. Mota A Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737 [TBL] [Abstract][Full Text] [Related]
29. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Mikhalski D; Wissing KM; Ghisdal L; Broeders N; Touly M; Hoang AD; Loi P; Mboti F; Donckier V; Vereerstraeten P; Abramowicz D Transplantation; 2008 Apr; 85(7 Suppl):S3-9. PubMed ID: 18401260 [TBL] [Abstract][Full Text] [Related]
30. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression. Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704 [TBL] [Abstract][Full Text] [Related]
31. Conversion of ciclosporin A to tacrolimus in kidney transplant recipients with chronic allograft nephropathy. Tang SC; Chan KW; Tang CS; Lam MF; Leung CY; Tse KC; Li CS; Ho YW; Tong MK; Lai KN; Chan TM; Nephrol Dial Transplant; 2006 Nov; 21(11):3243-51. PubMed ID: 16877482 [TBL] [Abstract][Full Text] [Related]
32. Outcome of renal transplants from pediatric donors <5 yr of age. El-Sabrout R; Buch K Clin Transplant; 2005 Jun; 19(3):316-20. PubMed ID: 15877791 [TBL] [Abstract][Full Text] [Related]
33. The role of tacrolimus in adult kidney transplantation: a review. Laskow DA; Neylan JF; Shapiro RS; Pirsch JD; Vergne-Marini PJ; Tomlanovich SJ Clin Transplant; 1998 Dec; 12(6):489-503. PubMed ID: 9850440 [TBL] [Abstract][Full Text] [Related]
34. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. Meier M; Nitschke M; Weidtmann B; Jabs WJ; Wong W; Suefke S; Steinhoff J; Fricke L Transplantation; 2006 Apr; 81(7):1035-40. PubMed ID: 16612281 [TBL] [Abstract][Full Text] [Related]
35. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. Opelz G; Döhler B; Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179 [TBL] [Abstract][Full Text] [Related]
36. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients. Pohanka E; Margreiter R; Sparacino V; Sperschneider H; Transplant Proc; 2005 May; 37(4):1874-6. PubMed ID: 15919490 [TBL] [Abstract][Full Text] [Related]
37. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients? Cheung CY; Liu YL; Wong KM; Chan HW; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Shek CC; Li CS Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256 [TBL] [Abstract][Full Text] [Related]
39. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762 [TBL] [Abstract][Full Text] [Related]
40. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. Rowshani AT; Scholten EM; Bemelman F; Eikmans M; Idu M; Roos-van Groningen MC; Surachno JS; Mallat MJ; Paul LC; de Fijter JW; Bajema IM; ten Berge I; Florquin S J Am Soc Nephrol; 2006 Jan; 17(1):305-12. PubMed ID: 16306168 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]